A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

Clinical trial NCT07102368 · RECRUITING

Trial details

NCT number: NCT07102368
Sponsor: Janssen-Cilag G.m.b.H
Status: RECRUITING
Study type: OBSERVATIONAL

Inflammatory Bowel Disease Colitis, Ulcerative Crohn's Disease

Start date: 2025-08-18
Primary completion: 2029-01-15
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.